IRADIMED CORP Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by IRADIMED CORPORATION on October 4, 2016. The report serves as a current disclosure pursuant to Regulation FD regarding a revision to the Company's financial guidance for the third quarter and full year of 2016.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a notice that guidance has been revised rather than a detailed financial statement.
Material Changes
The primary material change disclosed is the revision of financial guidance for the third quarter and full year 2016. The specific nature or magnitude of these revisions is not detailed in the body of this 8-K but is referenced in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Management Commentary
- Guidance Revision: The Company announced a revision to its third quarter and full year 2016 financial guidance.
- Conference Call: Management scheduled a conference call for October 4, 2016, at 8:30 AM Eastern Time to discuss the update.
- Legal Disclaimer: The information in this report and the accompanying exhibit is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and shall not be incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated October 4, 2016) for the specific numerical details of the revised guidance.
- Listen to the recording of the October 4, 2016 conference call for management's explanation of the guidance revision.
- Verify the impact of the guidance change on the Company's full-year 2016 projections.